Caveolae and L-type Calcium Channels in Cardiomyocytes
心肌细胞中的小凹和 L 型钙通道
基本信息
- 批准号:7439009
- 负责人:
- 金额:$ 36.37万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-06-01 至 2011-05-31
- 项目状态:已结题
- 来源:
- 关键词:AblationAddressAdultArrhythmiaAtrial FibrillationBiological AssayCardiacCardiac MyocytesCardiovascular DiseasesCaveolaeCell physiologyCellsComplexDataDiseaseDominant-Negative MutationElectron MicroscopyElectrophysiology (science)ExhibitsGene ExpressionGene MutationGoalsHeartHeart failureImmunoprecipitationKnock-outL-Type Calcium ChannelsLifeLocalizedLong QT SyndromeMacromolecular ComplexesMembraneMembrane MicrodomainsMicroscopyMolecularMusMuscle CellsMutationMyopathyNeonatalNot DefinedPopulationPopulation CharacteristicsProtein IsoformsProteinsRegulationRelative (related person)ResearchResearch PersonnelScaffolding ProteinSignal TransductionSkeletal systemSmall Interfering RNASurfaceTechniquesTransmission Electron MicroscopyVentricularbasecaveolin-3flotillingain of functionhemodynamicsin vivoinsightmature animalmouse modelmutantprogramsresearch studyresponsetraffickingvoltage
项目摘要
DESCRIPTION (provided by applicant): Project Summary: The influx of Ca through L-type Ca channels in surface membrane of cardiomyocytes regulates a variety of cellular processes including contraction, secretion, cell signaling, and gene expression. The long-term goals of this research are 1) to discriminate between distinct populations of L-type Ca channels in cardiomyocytes based on the unique macromolecular complex of associated proteins; 2) to determine how these different populations of channels specifically contribute to various Ca-regulated cellular processes; and 3) to understand how alterations in the different populations of Ca channels contribute to cardiovascular disease. These goals will be approached initially focusing on Cav1.2 L-type Ca channels localized to the specialized membrane microdomains known as caveolae which are defined by the signature protein caveolin-3 (Cav-3). The contribution of Cav1.2 channels to the genesis of the long QT syndrome associated with recently identified mutations in Cav-3 will be defined. Using immunoprecipitation techniques, GST-Cav-3 pull-down, immunoconfocal microscopy, immunogold electron microscopy, siRNA knockdown of targeted proteins, heterologous expression of Cav1.2 channels and key associate proteins, and conditional knockout of Cav-3 in mice, we will address three specific aims: 1) Define the relative abundance and composition of the Cav1.2 channels localized to caveolae in ventricular myocytes; 2) Determine if Cav-3 and associated core scaffolding proteins are essential for normal basal L-type Ca current and its (¿-AR regulation in ventricular myocytes; 3) Determine the impact of long QT-related Cav-3 genetic mutations on Cav1.2 L- type Ca channels.
Relevance: These studies will provide molecular definition of the subpopulation of Ca channel proteins localized to caveolae and thus offer mechanistic insights into the genesis of the long QT syndrome and life-threatening arrhythmias associated with mutations in the signature protein of caveolae in the heart, caveolin-3. Furthermore, this research will impact our understanding of heart failure and atrial fibrillation given that alterations in caveolae and Ca channels have been detected in these diseases. Ultimately, a molecular understanding of caveolae and L-type Ca2+ channels has the potential to inspire new therapies for these prevalent cardiovascular diseases.
描述(由申请人提供):项目概述:心肌细胞表面膜中通过L型Ca通道的Ca内流调节多种细胞过程,包括收缩、分泌、细胞信号传导和基因表达。本研究的长期目标是:1)基于相关蛋白的独特大分子复合物来区分心肌细胞中不同的L型Ca通道群体; 2)确定这些不同的通道群体如何特异性地促进各种Ca调节的细胞过程; 3)了解不同Ca通道群体的改变如何促进心血管疾病。这些目标将首先集中在Cav1.2 L型钙通道定位到专门的膜微区称为小窝,这是由签名蛋白小窝蛋白-3(Cav-3)定义。将定义Cav1.2通道对与最近发现的Cav-3突变相关的长QT综合征发生的贡献。本研究利用免疫沉淀技术、GST-Cav-3 pulldown技术、免疫共聚焦显微镜、免疫金电镜、siRNA敲除靶蛋白、Cav1.2通道及其关键相关蛋白的异源表达以及条件性敲除小鼠Cav-3等技术,主要研究三个方面的内容:1)明确心室肌细胞膜小窝Cav1.2通道的相对丰度和组成; 2)确定Cav-3和相关的核心支架蛋白是否是心室肌细胞中正常的基础L型Ca电流及其β-AR调节所必需的; 3)确定长QT相关的Cav-3基因突变对Cav 1.2 L型Ca通道的影响。
相关性:这些研究将提供定位于小窝的Ca通道蛋白亚群的分子定义,从而提供与心脏小窝的特征蛋白小窝蛋白-3突变相关的长QT综合征和危及生命的心律失常的发生机制的见解。此外,这项研究将影响我们对心力衰竭和房颤的理解,因为在这些疾病中已经检测到了小窝和钙通道的改变。最终,对小窝和L型Ca 2+通道的分子理解有可能激发这些流行心血管疾病的新疗法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Timothy J. Kamp其他文献
Engineering a robust and anisotropic cardiac-specific extracellular matrix scaffold for cardiac patch tissue engineering
为心脏补片组织工程设计坚固且各向异性的心脏特异性细胞外基质支架
- DOI:
10.1016/j.mbplus.2024.100151 - 发表时间:
2024 - 期刊:
- 影响因子:0
- 作者:
Te;Brandon Zhao;Richard Balbin;Sameeksha Sharma;Donggi Ha;Timothy J. Kamp;Yuxiao Zhou;Feng Zhao - 通讯作者:
Feng Zhao
Human pluripotent stem cell-derived cardiomyocytes for safety pharmacology applications
- DOI:
10.1016/j.vascn.2009.04.004 - 发表时间:
2009-09-01 - 期刊:
- 影响因子:
- 作者:
Timothy J. Kamp - 通讯作者:
Timothy J. Kamp
Génération de cardiomyocytes à partir de cellules souches pluripotentes humaines
人类多能细胞中心肌细胞的生成
- DOI:
- 发表时间:
2012 - 期刊:
- 影响因子:0
- 作者:
Sean P. Palecek;Timothy J. Kamp;Xiaojun Lian - 通讯作者:
Xiaojun Lian
Long QT Syndrome-Associated F97C and S141R Ca<sub>V</sub>-3 Mutations Exert Pleiotropic Effects on Cardiac L-Type Calcium Channels
- DOI:
10.1016/j.bpj.2011.11.708 - 发表时间:
2012-01-31 - 期刊:
- 影响因子:
- 作者:
Jason D. Foell;Jabe M. Best;David J. Tester;Michael J. Ackerman;Ravi C. Balijepalli;Timothy J. Kamp - 通讯作者:
Timothy J. Kamp
Characterization Of Human Embryonic Stem Cell-derived Cardiomyocyte Action Potentials And Channel Conductances Using A Theoretical Model
- DOI:
10.1016/j.bpj.2008.12.3512 - 发表时间:
2009-02-01 - 期刊:
- 影响因子:
- 作者:
Brian E. Carlson;Gisela F. Wilson;Jianhua Zhang;Timothy J. Kamp;Daniel A. Beard - 通讯作者:
Daniel A. Beard
Timothy J. Kamp的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Timothy J. Kamp', 18)}}的其他基金
Committed Cardiac Progenitors to Remuscularize the Failing Ischemic Heart
心脏祖细胞致力于使衰竭的缺血性心脏重新肌肉化
- 批准号:
9811091 - 财政年份:2019
- 资助金额:
$ 36.37万 - 项目类别:
Refining Cardiac Progenitor Cells for Myocardial Repair
精炼心脏祖细胞以修复心肌
- 批准号:
9109019 - 财政年份:2015
- 资助金额:
$ 36.37万 - 项目类别:
Refining Cardiac Progenitor Cells for Myocardial Repair
精炼心脏祖细胞以修复心肌
- 批准号:
8988235 - 财政年份:2015
- 资助金额:
$ 36.37万 - 项目类别:
Caveolae, T-type Calcium Channels and Cardiac Hypertrophy
小窝、T 型钙通道和心脏肥大
- 批准号:
8979699 - 财政年份:2012
- 资助金额:
$ 36.37万 - 项目类别:
Olympus FV1000 Livecell Confocal System
奥林巴斯 FV1000 Livecell 共聚焦系统
- 批准号:
8053625 - 财政年份:2011
- 资助金额:
$ 36.37万 - 项目类别:
SHARING IN THE DISCOVERY STEM CELL OUTREACH LEARNING LAB
在发现干细胞推广学习实验室中分享
- 批准号:
8358215 - 财政年份:2011
- 资助金额:
$ 36.37万 - 项目类别:
SHARING IN THE DISCOVERY STEM CELL OUTREACH LEARNING LAB
在发现干细胞推广学习实验室中分享
- 批准号:
8173111 - 财政年份:2010
- 资助金额:
$ 36.37万 - 项目类别:
Embryonic Stem Cell-based Therapies for Myocardial Infarction
基于胚胎干细胞的心肌梗塞疗法
- 批准号:
7637137 - 财政年份:2007
- 资助金额:
$ 36.37万 - 项目类别:
Caveolae and L-type Calcium Channels in Cardiomyocytes
心肌细胞中的小凹和 L 型钙通道
- 批准号:
7208180 - 财政年份:2007
- 资助金额:
$ 36.37万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 36.37万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 36.37万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 36.37万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 36.37万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 36.37万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 36.37万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 36.37万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 36.37万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 36.37万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 36.37万 - 项目类别:
Research Grant